Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 39% ± 14% | |
peripheral blood | 17 studies | 31% ± 10% | |
brain | 11 studies | 35% ± 15% | |
intestine | 9 studies | 33% ± 14% | |
eye | 9 studies | 32% ± 14% | |
kidney | 7 studies | 27% ± 10% | |
liver | 6 studies | 35% ± 23% | |
lymph node | 6 studies | 32% ± 20% | |
placenta | 5 studies | 22% ± 8% | |
bone marrow | 5 studies | 30% ± 7% | |
adipose | 5 studies | 19% ± 3% | |
uterus | 4 studies | 32% ± 19% | |
breast | 4 studies | 23% ± 1% | |
pancreas | 3 studies | 41% ± 15% | |
heart | 3 studies | 19% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 6171.95 | 21 / 21 | 100% | 38.80 | 504 / 504 |
esophagus | 100% | 8301.55 | 1445 / 1445 | 100% | 30.55 | 183 / 183 |
intestine | 100% | 7430.20 | 966 / 966 | 100% | 45.04 | 527 / 527 |
ovary | 100% | 4604.62 | 180 / 180 | 100% | 30.92 | 430 / 430 |
stomach | 100% | 4788.83 | 359 / 359 | 100% | 39.51 | 286 / 286 |
uterus | 100% | 5591.52 | 170 / 170 | 100% | 43.35 | 459 / 459 |
lung | 100% | 9101.91 | 578 / 578 | 100% | 30.27 | 1154 / 1155 |
breast | 100% | 6705.22 | 459 / 459 | 100% | 43.52 | 1117 / 1118 |
thymus | 100% | 5847.31 | 653 / 653 | 100% | 29.18 | 604 / 605 |
prostate | 100% | 5712.47 | 245 / 245 | 100% | 25.41 | 500 / 502 |
skin | 100% | 7845.57 | 1809 / 1809 | 100% | 22.70 | 470 / 472 |
brain | 99% | 4844.77 | 2620 / 2642 | 100% | 26.10 | 705 / 705 |
kidney | 100% | 4529.75 | 89 / 89 | 99% | 18.02 | 888 / 901 |
adrenal gland | 100% | 5539.07 | 258 / 258 | 97% | 20.39 | 224 / 230 |
pancreas | 95% | 2298.29 | 311 / 328 | 99% | 30.68 | 176 / 178 |
liver | 98% | 2403.50 | 221 / 226 | 93% | 14.75 | 379 / 406 |
adipose | 100% | 6967.10 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 39.07 | 29 / 29 |
peripheral blood | 100% | 11819.16 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 8814.48 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 40.89 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.02 | 1 / 1 |
muscle | 100% | 4571.48 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4803.35 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 4421.06 | 845 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 15.53 | 76 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045814 | Biological process | negative regulation of gene expression, epigenetic |
GO_0007549 | Biological process | sex-chromosome dosage compensation |
GO_0006281 | Biological process | DNA repair |
GO_1904815 | Biological process | negative regulation of protein localization to chromosome, telomeric region |
GO_0071169 | Biological process | establishment of protein localization to chromatin |
GO_0061187 | Biological process | regulation of rDNA heterochromatin formation |
GO_1902882 | Biological process | regulation of response to oxidative stress |
GO_0019216 | Biological process | regulation of lipid metabolic process |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_1902750 | Biological process | negative regulation of cell cycle G2/M phase transition |
GO_0031507 | Biological process | heterochromatin formation |
GO_0006334 | Biological process | nucleosome assembly |
GO_1901837 | Biological process | negative regulation of transcription of nucleolar large rRNA by RNA polymerase I |
GO_0034184 | Biological process | positive regulation of maintenance of mitotic sister chromatid cohesion |
GO_0002082 | Biological process | regulation of oxidative phosphorylation |
GO_1903226 | Biological process | positive regulation of endodermal cell differentiation |
GO_0040029 | Biological process | epigenetic regulation of gene expression |
GO_0045618 | Biological process | positive regulation of keratinocyte differentiation |
GO_1902688 | Biological process | regulation of NAD metabolic process |
GO_0045815 | Biological process | transcription initiation-coupled chromatin remodeling |
GO_0071901 | Biological process | negative regulation of protein serine/threonine kinase activity |
GO_0005730 | Cellular component | nucleolus |
GO_0000786 | Cellular component | nucleosome |
GO_0000228 | Cellular component | nuclear chromosome |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0001740 | Cellular component | Barr body |
GO_0001739 | Cellular component | sex chromatin |
GO_0090734 | Cellular component | site of DNA damage |
GO_0005721 | Cellular component | pericentric heterochromatin |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0000793 | Cellular component | condensed chromosome |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0160004 | Molecular function | poly-ADP-D-ribose modification-dependent protein binding |
GO_1990841 | Molecular function | promoter-specific chromatin binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0031492 | Molecular function | nucleosomal DNA binding |
GO_0030291 | Molecular function | protein serine/threonine kinase inhibitor activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0030527 | Molecular function | structural constituent of chromatin |
GO_0010385 | Molecular function | double-stranded methylated DNA binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0031490 | Molecular function | chromatin DNA binding |
GO_0000182 | Molecular function | rDNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MACROH2A1 |
Protein name | MacroH2A.1 histone Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (Histone H2A.y) (H2A/y) (Medulloblastoma antigen MU-MB-50.205) Histone H2A |
Synonyms | H2AFY |
Description | FUNCTION: Variant histone H2A which replaces conventional H2A in a subset of nucleosomes where it represses transcription . Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template . Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability . DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. Involved in stable X chromosome inactivation . Inhibits the binding of transcription factors, including NF-kappa-B, and interferes with the activity of remodeling SWI/SNF complexes . Inhibits histone acetylation by EP300 and recruits class I HDACs, which induces a hypoacetylated state of chromatin . .; FUNCTION: [Isoform 1]: Isoform that specifically binds poly-ADP-ribose and O-acetyl-ADP-ribose and plays a key role in NAD(+) metabolism . Able to bind to the ends of poly-ADP-ribose chains created by PARP1 and cap them (By similarity). This prevents PARP1 from further addition of ADP-ribose and thus limits the consumption of nuclear NAD(+), allowing the cell to maintain proper NAD(+) levels in both the nucleus and the mitochondria to promote proper mitochondrial respiration (By similarity). Increases the expression of genes involved in redox metabolism, including SOD3 . .; FUNCTION: [Isoform 2]: In contrast to isoform 1, does not bind poly-ADP-ribose . Represses SOD3 gene expression . . |
Accessions | A0A8I5KRC6 B4DJC3 ENST00000304332.8 [O75367-3] ENST00000687629.1 ENST00000688649.1 ENST00000312469.8 [O75367-2] D6RCF2 O75367 ENST00000510038.1 [O75367-1] ENST00000511689.6 [O75367-1] A0A994J4J7 A0A8I5KS04 ENST00000423969.6 ENST00000506671.5 ENST00000513210.6 |